Research ArticleOriginal Research
Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
Shawna V. Hudson, Pamela Ohman-Strickland, Jeanne M. Ferrante, Grace Lu-Yao, A. John Orzano and Benjamin F. Crabtree
The Journal of the American Board of Family
Medicine May 2009, 22 (3) 257-265; DOI: https://doi.org/10.3122/jabfm.2009.03.080136
Shawna V. Hudson
Pamela Ohman-Strickland
Jeanne M. Ferrante
Grace Lu-Yao
A. John Orzano

References
- ↵Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66.
- ↵Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med 2002; 113: 663–7.
- ↵Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289: 1414–20.
- ↵Screening for prostate cancer. American College of Physicians. Ann Intern Med 1997; 126: 480–4.
- Carroll P, Coley C, McLeod D, et al. Prostate-specific antigen best practice policy–part I: early detection and diagnosis of prostate cancer. Urology 2001; 57: 217–24.
- Ferrini R, Woolf SH. American College of Preventive Medicine practice policy. Screening for prostate cancer in American men. Am J Prev Med 1998; 15: 81–4.
- ↵Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin 2005; 55: 31–44.
- ↵US Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med 2002; 137: 915–6.
- ↵Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. Arch Fam Med 1997; 6: 453–8.
- ↵
- ↵Edlefsen KL, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N. Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use? Am J Prev Med 1999; 17: 87–90.
- Hoffman RM, Papenfuss MR, Buller DB, Moon TE. Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prev Med 1996; 12: 277–81.
- Lawson DA, Simoes EJ, Sharp D, et al. Prostate cancer screening–a physician survey in Missouri. J Community Health 1998; 23: 347–58.
- Purvis Cooper C, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians’ use of the PSA test. Prev Med 2004; 38: 182–91.
- Voss JD, Schectman JM. Prostate cancer screening practices and beliefs [see comment]. J Gen Intern Med 2001; 16: 831–7.
- ↵Han PK, Coates RJ, Uhler RJ, Breen N. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000. Am J Prev Med 2006; 30: 394–404.
- ↵Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ. Behavioral associations between prostate and colon cancer screening. J Am Coll Surg 2005; 200: 216–23.
- ↵Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW. Factors influencing use of the prostate-specific antigen screening test in primary care. Am J Manag Care 2000; 6: 315–24.
- ↵
- Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med 2004; 164: 1858–64.
- ↵Lu-Yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 2003; 95: 1792–7.
- ↵Yao SL, Lu-Yao G. Understanding and appreciating overdiagnosis in the PSA era. J Natl Cancer Inst 2002; 94: 958–60.
- ↵US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185–91.
- ↵Fall K, Garmo H, Andren O, et al. Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst 2007; 99: 526–32.
- ↵Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977–84.
- Wong YN, Mitra N, Hudes G, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006; 296: 2683–93.
- Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781–9.
- ↵Lu-Yao GL, Friedman M, Yao SL. Use of radical prostatectomy among Medicare beneficiaries before and after the introduction of prostate specific antigen testing. J Urol 1997; 157: 2219–22.
- ↵Kerfoot BP, Holmberg EF, Lawler EV, Krupat E, Conlin PR. Practitioner-level determinants of inappropriate prostate-specific antigen screening. Arch Intern Med 2007; 167: 1367–72.
- ↵Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA 2006; 296: 2336–42.
- ↵Scales CD, Jr., Curtis LH, Norris RD, Schulman KA, Albala DM, Moul JW. Prostate specific antigen testing in men older than 75 years in the United States. J Urol 2006; 176: 511–4.
- ↵Draisma G, Boer R, Otto SJ, et al. Lead times and Overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003; 95: 868–78.
- ↵Dickey LL, Kamerow DB. Primary care physicians’ use of office resources in the provision of preventive care. Arch Fam Med 1996; 5: 399–404.
- ↵
- Hudson SV, Ohman-Strickland P, Cunningham R, Ferrante JM, Hahn K, Crabtree BF. The effects of teamwork and system support on colorectal cancer screening in primary care practices. Cancer Detect Prev 2007; 31: 417–23.
- Dietrich AJ, O'Connor GT, Keller A, Carney PA, Levy D, Whaley FS. Cancer: improving early detection and prevention. A community practice randomised trial. BMJ 1992; 304: 687–91.
- ↵Jaen CR, McIlvain H, Pol L, Phillips RL Jr, Flocke S, Crabtree BF. Tailoring tobacco counseling to the competing demands in the clinical encounter. J Fam Pract 2001; 50: 859–63.
- Jaen CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994; 38: 166–71.
- Jaen CR, Stange KC, Tumiel LM, Nutting P. Missed opportunities for prevention: smoking cessation counseling and the competing demands of practice. J Fam Pract 1997; 45: 348–54.
- ↵Carney PA, Dietrich AJ, Keller A, Landgraf J, O'Connor GT. Tools, teamwork, and tenacity: an office system for cancer prevention. J Fam Pract 1992; 35: 388–94.
- Carpiano RM, Flocke SA, Frank SH, Stange KC. Tools, teamwork, and tenacity: an examination of family practice office system influences on preventive service delivery. Prev Med 2003; 36: 131–40.
- Crabtree BF, Miller WL, Aita VA, Flocke SA, Stange KC. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract 1998; 46: 403–9.
- Stange KC. One size doesn't fit all. Multimethod research yields new insights into interventions to increase prevention in family practice. J Fam Pract 1996; 43: 358–60.
- ↵Crabtree BF, Miller WL, Stange KC. Understanding practice from the ground up. J Fam Pract 2001; 50: 881–7.
- ↵
- ↵Hudson SV, Harris-Haywood S, Stange KC, Orzano AJ, Crabtree BF. Recruiting minority primary care practices into practice-based research. Med Care 2006; 44: 696–700.
- ↵
- ↵Ohman-Strickland PA, John Orzano A, Nutting PA, et al. Measuring organizational attributes of primary care practices: development of a new instrument. Health Serv Res 2007; 42: 1257–73.
- ↵
- ↵Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004; 38: 732–44.
- ↵Institutes of Medicine. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press; 2001.
- ↵Guerra CE, Jacobs SE, Holmes JH, Shea JA. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med 2007; 22: 901–7.
- ↵Lamplugh M, Gilmore P, Quinlan T, Cornford P. PSA testing: are patients aware of what lies ahead? Ann R Coll Surg Engl 2006; 88: 284–8.
- ↵Krist AH, Woolf SH, Johnson RE. How physicians approach prostate cancer screening before and after losing a lawsuit. Ann Fam Med 2007; 5: 120–5.
- ↵Merenstein D. A piece of my mind. Winners and losers. JAMA 2004; 291: 15–6.
- ↵American Urological Association. Guideline on the management of benign prostatic hyperplasia (BPH). 2003, updated 2006. Available at http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm. Accessed 18 March 2009.
In this issue
Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
Shawna V. Hudson, Pamela Ohman-Strickland, Jeanne M. Ferrante, Grace Lu-Yao, A. John Orzano, Benjamin F. Crabtree
The Journal of the American Board of Family
Medicine May 2009, 22 (3) 257-265; DOI: 10.3122/jabfm.2009.03.080136
Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
Shawna V. Hudson, Pamela Ohman-Strickland, Jeanne M. Ferrante, Grace Lu-Yao, A. John Orzano, Benjamin F. Crabtree
The Journal of the American Board of Family
Medicine May 2009, 22 (3) 257-265; DOI: 10.3122/jabfm.2009.03.080136
Jump to section
Related Articles
- No related articles found.
Cited By...
- Response: Re: Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
- Re: Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
- Providing Quality Primary Care to Older Adults
- In This Issue: Mini-Theme on Geriatric Care and Cancer Screening